UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Radical prostatectomy after vascular-targeted photodynamic therapy (VTP) with TOOKAD® : feasibility, early and intermediate results

Pierrard, V; Lebdai, S; Kleinclauss, F; Azzouzi, A-R; Terrier, JE; Fortier, E; Joniau, S; ... Ruffion, A; + view all (2019) Radical prostatectomy after vascular-targeted photodynamic therapy (VTP) with TOOKAD® : feasibility, early and intermediate results. The Journal of Urology , 201 (2) pp. 315-321. 10.1016/j.juro.2018.08.084. Green open access

[thumbnail of 1-s2.0-S0022534718439122-main.pdf]
Preview
Text
1-s2.0-S0022534718439122-main.pdf - Accepted Version

Download (282kB) | Preview

Abstract

INTRODUCTION: and objectives: vascular-targeted photodynamic therapy with TOOKAD® (VTP) is a new therapeutic option for localized prostate cancer (PCa) management. The objectives are to assess the feasibility of radical prostatectomy (RP) after VTP and describe functional and oncological outcomes. MATERIAL AND METHODS: we retrospectively included 45 patients who underwent salvage RP after VTP for recurrent PCa in 14 surgical centres in Europe between October 2008 and March 2017.Forty-two RP were performed: 16 robot-assisted, 6 by laparoscopy, and 20 by open surgery. Primary endpoints were morbidity and technical difficulties. Secondary endpoints were early and intermediate post-operative functional and oncologic outcomes. RESULTS: Median operative time was 180 (150-223) minutes. Median blood loss was 200 (155-363) millilitres. According to the surgeons, the surgery was "easy" for 29 patients (69%), "difficult" for 13 patients (31%). Nerve sparing was feasible for 14 patients (33%). Five (12%) post-operative complications were found: 2 Claviens I, 2 Clavien II and 1 Clavien IIIB. There was 13 pT3 (31%), 21 (50%) pT2c. Surgical margins were positive for 13 patients (31%). PSA was undetectable at 6-12 months for 37 patients (88%). Nine patients had complementary radiotherapy. Four patients had a last PSA > 0.2 ng/mL with a median follow-up of 23 (12-36) months. At one year, 27 patients (64%) were completely continent (no pads), 10 (24%) had low incontinence (1 pads). Four patients (11 %) recovered potency without treatment, and 23 (64%) with appropriate treatment. CONCLUSION: Salvage RP after VTP treatment was feasible and safe without difficulties for most of the surgeons.

Type: Article
Title: Radical prostatectomy after vascular-targeted photodynamic therapy (VTP) with TOOKAD® : feasibility, early and intermediate results
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.juro.2018.08.084
Publisher version: https://doi.org/10.1016/j.juro.2018.08.084
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Focal therapy, Radical prostatectomy, Vascular-targeted photodynamic therapy, functional outcomes, salvage prostatectomy
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10058046
Downloads since deposit
1,904Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item